Search the Community

The Global Diabetes Care Devices Market is expected to exceed more than US$ 30.25 Billion by 2022 at a CAGR of 5.9% in the given forecast period Browse Full Report:https://www.marketresearchengine.com/diabetes-care-devices-market The Global Diabetes Care Devices Market is segmented on the lines of its glucose monitoring devices, insulin delivery device, type and regional. Based on glucose monitoring device segmentation it covers blood glucose meters, blood glucose test strips, lancing devices, continuous glucose monitoring devices, HbA1c testing kits. Based on insulin delivery device segmentation it covers insulin pumps, insulin syringes and insulin pens. Based on type segmentation it covers therapy type, inject able, oral drugs. The major driving factors of Global Diabetes Care Devices Market are as follows: Increasing prevalence of diabetes care patients Development of technologies for diabetes Rising minimum or non-invasive products Growing awareness of diabetes care devices Development need for faster, safer and effective method of diagnosis and treatment of diabetes The restraining factors of Global Diabetes Care Devices Market are as follows: Expensive related with diagnosis and treatment Compensation issues and patent expiry This report provides: 1) An overview of the global market for Global Diabetes Care Devices Market and related technologies. 2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. 3) Identifications of new market opportunities and targeted promotional plans for Global Diabetes Care Devices Market. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry. The Global Diabetes Care Devices Market has been segmented as below: By Glucose Monitoring Devices Analysis: Blood Glucose Meters Blood Glucose Test Strips Lancing Devices Continuous Glucose Monitoring Devices HbA1c Testing Kits By Insulin Delivery Devices Analysis: Insulin Pumps Insulin Syringes Insulin Pens By Type Analysis: Therapy Type Injectable Oral Drugs By Regional Analysis: North America Europe Asia-Pacific Rest of the World Reasons to Buy this Report: 1) Obtain the most up to date information available on all Global Diabetes Care Devices Market. 2) Identify growth segments and opportunities in the industry. 3) Facilitate decision making on the basis of strong historic and forecast of Global Diabetes Care Devices Market data. 4) Assess your competitor's refining portfolio and its evolution.

Date: November 28, 2017 Source: The Lancet Summary: Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 - equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI. When considered individually, 544300 cases of cases were attributable to high BMI (equivalent to 3.9% of all cancers), and 280100 were attributable to diabetes (2%). Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 -- equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology journal. https://www.sciencedaily.com/releases/2017/11/171128092315.htm

A large study has found that body mass index, waist circumference and diabetes are all associated with an increased risk for liver cancer. Liver cancer is the sixth most common cancer, and its incidence has tripled since the mid-1970s in the United States. For the study, in Cancer Research, researchers pooled data from 14 prospective studies with more than 1.5 million participants. After controlling for age, sex, alcohol use, smoking and race, they found that being overweight increased the relative risk for liver cancer by between 21 percent and 142 percent as B.M.I. increased. For each 2-inch increase in waist circumference, the risk of liver cancer increased by 8 percent, even after controlling for B.M.I. And those with Type 2 diabetes had more than double the risk of liver cancer, even among the non-obese. There was no association of B.M.I. with cancer if the patient had hepatitis, a cause of liver cancer so strong that it overwhelms any other cause. But among those without hepatitis, the increased risk was significant. “This study underscores that the parallel increase in obesity is part of the increase in liver cancer rates,” said the lead author, Peter T. Campbell, an epidemiologist with the American Cancer Society. “Now we have to accept the fact that obesity and Type 2 diabetes are strongly associated with liver cancer.” http://www.nytimes.com/2016/10/18/well/live/obesity-and-diabetes-tied-to-liver-cancer.html?_r=0